7 Prevalence and Severity of Obstructive Sleep Apnea in Men with Polycythemia on Testosterone Therapy. Issue 1 (1st April 2022)
- Record Type:
- Journal Article
- Title:
- 7 Prevalence and Severity of Obstructive Sleep Apnea in Men with Polycythemia on Testosterone Therapy. Issue 1 (1st April 2022)
- Main Title:
- 7 Prevalence and Severity of Obstructive Sleep Apnea in Men with Polycythemia on Testosterone Therapy
- Authors:
- Salter, C
Flores, JMF
Schofield, E
Tan, M
Mulhall, J - Abstract:
- ABSTRACT: Introduction: Polycythemia is independently associated with both testosterone therapy (TTH) and obstructive sleep apnea (OSA). Objective: The purpose of this study was to evaluate the prevalence and severity of OSA in men who experience polycythemia while on TTH. Methods: Study population included men who had polycythemia [hematocrit (HCT) >50%] while on TTH for TD, with total and free T levels within the normal range. Men completed screening questionnaires for OSA and daytime sleepiness, respectively: STOP-BANG (SB, range 0-8) and the Epworth Sleepiness Scale (ESS, range 0-24). Men whose scores demonstrated intermediate to high risk of OSA proceeded to a diagnostic sleep study which recorded the following parameters: apnea hypoxia index (AHI, normal <5 events/h), total duration SpO2 saturation <88% and SpO2 nadir. Descriptive statistics are presented. Results: 73 men had a mean age of 60±11.5 years. Mean HCT pre-TTH and on TTH were 45±3% and 52±1.5%, respectively, for a mean increase of 6.6±3.6%. Mean on-treatment total T level 686±285 ng/dL. Median STOP-BANG score was 4 (IQR 3-5), median ESS score was 5 (IQR 3-9). 63% of patients screened positive for OSA on questionnaires. 81% of sleep studies confirmed OSA; mean AHI of the group was 15.4±13.2 events/hour (range 1.6-54.6 events/hour). 36% of men had AHI≥15 events/hour and 14% ≥30 AHI events/hour. Mean SpO2 nadir was 83±5% (range 69%-93%). 67% of men with OSA had an oxygen nadir in the 80s, 19% in the 70s and 3%ABSTRACT: Introduction: Polycythemia is independently associated with both testosterone therapy (TTH) and obstructive sleep apnea (OSA). Objective: The purpose of this study was to evaluate the prevalence and severity of OSA in men who experience polycythemia while on TTH. Methods: Study population included men who had polycythemia [hematocrit (HCT) >50%] while on TTH for TD, with total and free T levels within the normal range. Men completed screening questionnaires for OSA and daytime sleepiness, respectively: STOP-BANG (SB, range 0-8) and the Epworth Sleepiness Scale (ESS, range 0-24). Men whose scores demonstrated intermediate to high risk of OSA proceeded to a diagnostic sleep study which recorded the following parameters: apnea hypoxia index (AHI, normal <5 events/h), total duration SpO2 saturation <88% and SpO2 nadir. Descriptive statistics are presented. Results: 73 men had a mean age of 60±11.5 years. Mean HCT pre-TTH and on TTH were 45±3% and 52±1.5%, respectively, for a mean increase of 6.6±3.6%. Mean on-treatment total T level 686±285 ng/dL. Median STOP-BANG score was 4 (IQR 3-5), median ESS score was 5 (IQR 3-9). 63% of patients screened positive for OSA on questionnaires. 81% of sleep studies confirmed OSA; mean AHI of the group was 15.4±13.2 events/hour (range 1.6-54.6 events/hour). 36% of men had AHI≥15 events/hour and 14% ≥30 AHI events/hour. Mean SpO2 nadir was 83±5% (range 69%-93%). 67% of men with OSA had an oxygen nadir in the 80s, 19% in the 70s and 3% in the 60s. Total duration of hypoxia (SpO2 ≤88%) was 32±50 minutes (range 0.1-202 minutes), 46% of men having hypoxia <10 minutes, 8% 10-20 minutes, 19% 70-150 minutes. Conclusions: Men on TTH who are eugonadal that experience polycythemia have high rates of OSA. 80% of the patients undergoing sleep study had OSA. These data suggest that men with polycythemia on TTH should be screened for OSA. Disclosure: No … (more)
- Is Part Of:
- Journal of sexual medicine. Volume 19:Issue 1(2022)Supplement
- Journal:
- Journal of sexual medicine
- Issue:
- Volume 19:Issue 1(2022)Supplement
- Issue Display:
- Volume 19, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 19
- Issue:
- 1
- Issue Sort Value:
- 2022-0019-0001-0000
- Page Start:
- S4
- Page End:
- S4
- Publication Date:
- 2022-04-01
- Subjects:
- Sexual disorders -- Periodicals
Sex -- Periodicals
Sexual health -- Periodicals
616.69005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1743-6109 ↗
http://www.blackwell-synergy.com/openurl?genre=journal&eissn=1743-6109 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=jsm ↗
https://academic.oup.com/jsm ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.jsxm.2022.01.018 ↗
- Languages:
- English
- ISSNs:
- 1743-6095
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5064.060000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26721.xml